Welcome remarks
Wanessa T. Clemente (BR)
Transplant Infectious Diseases (TID)
Transplant Infectious Diseases (TID)
|
Organized by
|
In collaboration with
|
Description
The Transplant Infectious Diseases (TID) Pre-Congress Program, Innovation through Collaboration, is an in-depth scientific meeting designed to address current and emerging challenges in infections affecting transplant recipients. The program brings together international experts for state-of-the-art lectures, case-based discussions, and interactive panels, with a strong emphasis on practical clinical decision-making and global perspectives.
The agenda is structured into four complementary sessions, covering donor-derived and unexpected transmissions; complex infections in vulnerable transplant recipients; major controversies in transplant infectious diseases; and TID education, research networks, and global collaboration. Across these sessions, key topics encompass viral, bacterial, fungal, parasitic, and mycobacterial infections, antimicrobial resistance, emerging pathogens in the context of climate change, advances in diagnostics and therapeutics, and the interface between infection and novel immunosuppressive strategies.
TID 1: Pushing the boundaries and unexpected transmissions
Chairs
Benjamin Teh (AU)
· Cameron R. Wolfe (US)
Presentations
Welcome Remarks
Matthew Roberts (AU)
Changing climates, changing viruses: The arboviral surge
Wanessa T. Clemente (BR)
HIV in transplantation: Past lessons, future directions
Peter G. Stock (US)
Microbiology on the fast track
Maricar Malinis (US)
Unrecognized fungal infections
John W. Baddley (US)
TID 2: Case based discussion: recipient syndromes- is it a DDI?
Chairs
Camille N. Kotton (US)
· Helen Opdam (AU)
Presentations
Case 1
Kanthi Vemuri (AU)
Case 2
Beatrice Sim (AU)
Case 3
Matthew Roberts (AU)
Panelists
Cameron R. Wolfe (US)
Panelists
Stephanie M. Pouch (US)
Coffee Break
No lectures assigned yet.
TID 3: Challenging bugs in vulnerable hosts: Diagnosis, treatment and prevention
Presentations
New approaches (diagnostics and treatments)
Priscilla Rupali (IN)
Tackling HHV-8: From risk to management. Global perspectives (Include perspective from different sites, application to AU/NZ)
Tina Marinelli (AU)
Where do new drugs fit and AMS
Jonathan Hand (US)
(Re)emerging vaccine preventable infections and immunisation approaches
Camille N. Kotton (US)
(Re)emerging vaccine preventable infections and immunisation approaches
Benjamin Teh (AU)
Lunch Break
No lectures assigned yet.
TID 4: Controversies (Cases and discussion panel in haematologic malignancy)
Presentations
Refractory CMV
Bradley Gardiner (AU)
From mutation to medication: Current perspectives on respiratory viruses
Stephanie M. Pouch (US)
NAM
Monica Slavin (AU)
Parasitic challenges in transplantation across non-endemic settings
Rebekah Lane (NZ)
Parasitic challenges in transplantation across endemic settings
Siriorn Watcharananan (TH)
What the ID physician needs to know about new immunosuppression
Olivia Smibert (AU)
Final Remarks
Wanessa T. Clemente (BR)